Prenatal and Newborn Genetic Testing Market, Top key players are World Health Organization, UAE Genetic Diseases Association, and Centre for Arab Genomic Studies, National Health Service (NHS), Centers for Disease Control and Prevention, National Human Ge
The global Prenatal and Newborn Genetic Testing Market is expected to reach US$ 11,204.74 Mn in 2027 from US$ 4,034.37 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027.
opportunities in emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years.
Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants.
Moreover, these diseases are also responsible for infant mortality across the globe. For instance, according to the World Health Organization 2016, an estimated 7.9 million infants across the world are born with genetic defects. Moreover, according to the Centers for Disease Control and Prevention (CDC), birth defects affect every 1 in 33 babies born in the US. On the other hand, a chromosomal abnormality such as Down syndrome affects 1 in 691 babies born in the US, as per the CDC’s data in 2017. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.
Get sample copy of this report@ https://bit.ly/2Tea3CO
Some of the key players operating in this market include: World Health Organization, UAE Genetic Diseases Association, and Centre for Arab Genomic Studies, National Health Service (NHS), Centers for Disease Control and Prevention, National Human Genome Research Institute (US), Florida Department of Health and others.
Global Prenatal and Newborn Genetic Testing Market was segmented by product, disease indication, and end user. The product segment was further divided as diagnostic and screening. On the basis of disease indication, the market is segmented into the cystic fibrosis, sickle cell anemia, Down syndrome, phenylketonuria, and other diseases. Based on the end user, the prenatal and newborn genetic testing market is segmented into hospitals and clinics, diagnostic centers, other end users. The hospitals and clinics held a major market share among the end user segment as they are the primary healthcare centres for all patients.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
TABLE OF CONTENT:
2. Global Prenatal And Newborn Genetic Testing Market - Key Takeaways
3. Research Methodology
4. Global Prenatal And Newborn Genetic Testing- Market Landscape
5. Global Prenatal And Newborn Genetic Testing Market - Key Industry Dynamics
6. Prenatal And Newborn Genetic Testing Market - Global Analysis
7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Product
8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - Disease Indication
9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 - End User
10. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 - Geographical Analysis
11. Prenatal And Newborn Genetic Testing Market - Industry Landscape
12. Prenatal And Newborn Genetic Testing Market-Key Company Profiles
Download PDF Brochure @ https://bit.ly/2Tea3CO
Manager - Partner Relations & International Marketing
Ph: +44-020-3286-9338 (UK)
Ph: +1-214-736-7666 (US)
Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prenatal and Newborn Genetic Testing Market, Top key players are World Health Organization, UAE Genetic Diseases Association, and Centre for Arab Genomic Studies, National Health Service (NHS), Centers for Disease Control and Prevention, National Human Ge here
News-ID: 1819816 • Views: 436
More Releases from REPORTSANDMARKETS
Research on Product Stewardship Market 2020, Provides Detail Analysis by Share, …
This report provides a complete overview of the Product Stewardship market profile, starting from the basic market information. The report discusses the industry where the products or services are applicable, and the technological advancements taking place in these industries. The report categorizes the market based on different segments, such as product types, end-users, which would provide the companies a complete knowledge of the product or service. This information analyzes the
Trends in Global Web-to-Print (W2P) Software Solutions Market 2020,(Impact of Co …
Overview The global Web-to-Print (W2P) Software Solutions market is relied upon to attain significant development in the coming years according to the distributed report published on the same. This development of the market can be credited to various key factors. These factors are comprehended and broken down by taking different parameters into consideration. Request the Sample Copy of Report Here @ https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-web-to-print-w2p-software-solutions-market-size-status-and-forecast-2020-2026?utm_source=openpr&utm_medium=15 Our experts cautiously investigate the market and its future
Supply Chain Big Data Analytics Market Outlook 2020-2026 (Covid-19 Impact) In-de …
Market Overview The report on the global Supply Chain Big Data Analytics market is an aftereffect of an effective and committed methodology by our group of research specialists. The report exhibits each part of the market in the most accurate and organized way conceivable. To begin with, the report offers key data about the arrangement or administration of the product or service, its definition, continuous patterns or trends, and applications.
Proximity Mobile Payment Market (Post impact of COVID-19) with Top Players: Sams …
Global Proximity Mobile Payment Market The global Proximity Mobile Payment market has been comprehensively analyzed and the results are presented in the market report published. The market concentration that is currently occupied by the Proximity Mobile Payment market and an overview of the Proximity Mobile Payment manufacturing industry is extensively researched in the report. An analysis of the collected data is used to reveal the market revenue earned by the different
More Releases for Genetic
Preimplantation Genetic Diagnosis: Scope & Revenue Outlook
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the
Preimplantation Genetic Testing Market-Size Report 2022
Preimplantation Genetic Testing Market by type 2017-2022 by new Service spreads across 204 pages profiling 17 companies and supported with 85 tables and 42 figures available at ReportsnReports.com Get sample copy for information professional insights@ http://www.reportsnreports.com/contacts/requestsample.aspx?name=1128201 “Preimplantation Genetic Testing Market projected to grow at a CAGR of 10.0%” The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4million in 2017, at a CAGR
India Genetic Testing Market Analysis
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest causes of mortality in neonates in cities. The ability to identify these non-communicable diseases at an early stage lies within the genetic screening segment. Genetic screening, however, is still in its infancy and there are many challenges that need to be overcome in order to
RBD Creative partners with Reproductive Genetic Innovations
Acknowledged in D Business' Faces of Detroit in 2015, RBD Creative, a local Plymouth marketing and design studio, is proud to announce a new partnership with Reproductive Genetic Innovations (RGI) of Northbrook, IL. RBD Creative specializes in health and wellness marketing solutions and has several notable clients including: University of Michigan Health System, University of Michigan School of Medicine, Lakes Urgent Care, Evangelical Homes of Michigan, Cryowellness USA, Michigan Reproductive
Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder
The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region. However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that
OGT aids research into molecular genetic disease
Unique CytoSure™ Molecular Testing Arrays provide high throughput CNV detection for multiple disorders on a single chip Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a new range of CytoSure™ Molecular Testing Arrays and Panels. The new DNA microarrays utilise a unique collection of probes for detecting copy number variations (CNVs) within genes associated with a variety of disorders. Three